While our studies do not address this aspect of AD pathogenesis, our data suggest that, similar to Aβ, the accumulation of pathogenic oligomeric forms of tau exacerbate vascular dysfunction, contributing together with Aβ to establish a feed-forward loop of vascular damage with Aβ and pathogenic oligomeric tau accumulation during the progression of AD. Here, MAPT is linked to Alzheimer disease.